Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults.
Pedrazzoli P, Ledermann JA, Lotz JP, Leyvraz S, Aglietta M, Rosti G, Champion KM, Secondino S, Selle F, Ketterer N, Grignani G, Siena S, Demirer T; European Group for Blood and Marrow Transplantation (EBMT) Solid Tumors Working Party. Pedrazzoli P, et al. Among authors: ketterer n. Ann Oncol. 2006 Oct;17(10):1479-88. doi: 10.1093/annonc/mdl044. Epub 2006 Mar 17. Ann Oncol. 2006. PMID: 16547069 Free article. Review.
[Overview on cancer in young adults].
Nay C, Luthi F, Ketterer N, Bauer J, Leyvraz S. Nay C, et al. Among authors: ketterer n. Rev Med Suisse. 2007 May 23;3(112):1305-6, 1308-10. Rev Med Suisse. 2007. PMID: 17596066 Review. French.
Sequential high-dose combination chemotherapy with granulocyte colony-stimulating factor and peripheral blood progenitor cells in patients with solid tumors: intensification limited by nonhematologic toxic effects.
Leyvraz S, Ketterer N, Vuichard P, von Fliedner V, Lejeune F, Schneider P, Grob JP, Bachmann F. Leyvraz S, et al. Among authors: ketterer n. J Natl Cancer Inst. 1993 Dec 1;85(23):1962-4. doi: 10.1093/jnci/85.23.1962. J Natl Cancer Inst. 1993. PMID: 7693957 No abstract available.
Intensification of chemotherapy for the treatment of solid tumours: feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony-stimulating factor.
Leyvraz S, Ketterer N, Perey L, Bauer J, Vuichard P, Grob JP, Schneider P, von Fliedner V, Lejeune F, Bachmann F. Leyvraz S, et al. Among authors: ketterer n. Br J Cancer. 1995 Jul;72(1):178-82. doi: 10.1038/bjc.1995.298. Br J Cancer. 1995. PMID: 7541235 Free PMC article.
[New systemic therapies in oncology].
Zaman K, Ketterer N, Vulliémoz D, Stupp R, Leyvraz S. Zaman K, et al. Among authors: ketterer n. Rev Med Suisse. 2005 May 18;1(20):1361-2, 1364-5. Rev Med Suisse. 2005. PMID: 15991629 Review. French.
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).
Ketterer N, Coiffier B, Thieblemont C, Fermé C, Brière J, Casasnovas O, Bologna S, Christian B, Connerotte T, Récher C, Bordessoule D, Fruchart C, Delarue R, Bonnet C, Morschhauser F, Anglaret B, Soussain C, Fabiani B, Tilly H, Haioun C. Ketterer N, et al. Ann Oncol. 2013 Apr;24(4):1032-7. doi: 10.1093/annonc/mds600. Epub 2012 Dec 12. Ann Oncol. 2013. PMID: 23235801 Free article. Clinical Trial.
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK).
Ghielmini M, Rufibach K, Salles G, Leoncini-Franscini L, Léger-Falandry C, Cogliatti S, Fey M, Martinelli G, Stahel R, Lohri A, Ketterer N, Wernli M, Cerny T, Schmitz SF. Ghielmini M, et al. Among authors: ketterer n. Ann Oncol. 2005 Oct;16(10):1675-82. doi: 10.1093/annonc/mdi320. Epub 2005 Jul 19. Ann Oncol. 2005. PMID: 16030029 Free article. Clinical Trial.
82 results